Free tool

Stocks above their 200-day average

We cover 561 companies trading above their own 200-day average. The median market value in the group is $1.24B. Across the group, the median move over the past trading day is −0.17%. 100% of the 561 with a 200-day average trade above it. Price change over the past year runs from −18.6% to +261.9% across the middle 80 percent of the group, with a median of +47.0%. Across the group, 5 companies currently carry a tier A volume signal.

Other lists in this group

Table

561 of 10,735 companies match these filters.Clear filters

TickerCompanyMarket cap (USD)Size1Y return
GRDXGridAI Technologies Corp.$28.75MMicro cap+111.52%
TXMDTherapeuticsMD, Inc.$26.39MMicro cap+103.57%
MRKRMarker Therapeutics, Inc.$24.18MMicro cap+54.26%
FEMYFemasys Inc.$23.87MMicro cap+711.11%
BFRIBiofrontera Inc.$22.72MMicro cap+77.91%
RVPRetractable Technologies, Inc.$21.85MMicro cap−12.05%
COCPCocrystal Pharma, Inc.$21.57MMicro cap−27.74%
CCMConcord Medical Services Holdings Limited$21.49MMicro cap−10.47%
ALLRAllarity Therapeutics, Inc.$21.32MMicro cap−15.72%
LFWDLifeward Ltd.$20.93MMicro cap+0.03%
PMIPicard Medical, Inc.$20.13MMicro cap+113.51%
NCELNewcelX Ltd.$19.52MMicro cap−84.77%
VYNEVYNE Therapeutics Inc$19.07MMicro cap+8660.74%
LEXXLexaria Bioscience Corp.$18.24MMicro cap+1146.05%
BCDABioCardia, Inc.$18.02MMicro cap−38.66%
CYCNCyclerion Therapeutics, Inc.$17.97MMicro cap+61.48%
BIVIBioVie Inc.$17.83MMicro cap+30.25%
ADILAdial Pharmaceuticals, Inc.$17.43MMicro cap−37.47%
CMMBChemomab Therapeutics Ltd.$16.85MMicro cap−25.57%
ADVBAdvanced Biomed Inc.$15.27MMicro cap+13.24%
PHIOPhio Pharmaceuticals Corp.$13.94MMicro cap−40.89%
HSCSHeartSciences Inc.$13.47MMicro cap−11.54%
APREAprea Therapeutics, Inc.$12.34MMicro cap−38.75%
ASBPAspire Biopharma Holdings, Inc.$11.68MMicro cap−60.93%
KPRXKiora Pharmaceuticals, Inc.$11.46MMicro cap−9.44%
TOVXTheriva Biologics, Inc.$11.16MMicro cap−42.10%
LUCYLucyd, Inc$9.73MMicro cap−42.05%
MBAICheck-Cap Ltd.$9.33MMicro cap+943.08%
BMGLBasel Medical Group Ltd$9.29MMicro cap+202.81%
IMRNImmuron Limited$9.20MMicro cap−35.77%
XBIOXenetic Biosciences, Inc.$9.04MMicro cap+35.92%
SKYESkye Bioscience, Inc.$8.92MMicro cap−41.62%
XWELXWELL, Inc.$8.55MMicro cap−6.93%
CNSPCNS Pharmaceuticals, Inc.$8.48MMicro cap−13.51%
NDRAENDRA Life Sciences Inc.$8.16MMicro cap+32.36%
ALZNAlzamend Neuro, Inc.$8.06MMicro cap−32.11%
NVNOenVVeno Medical Corporation$7.97MMicro cap−63.76%
ICCMIceCure Medical Ltd$7.85MMicro cap+132.49%
TRIBTrinity Biotech plc$7.80MMicro cap+547.97%
INMInMed Pharmaceuticals Inc.$7.64MMicro cap−36.44%
CURXCuranex Pharmaceuticals Inc$7.21MMicro cap−1.29%
JUNSJupiter Neurosciences, Inc.$6.66MMicro cap+236.24%
AMIXAutonomix Medical, Inc.$6.20MMicro cap+440.68%
LIMNLiminatus Pharma, Inc.$6.19MMicro cap+46.03%
HCWBHCW Biologics Inc.$4.96MMicro cap−55.15%
XAIRBeyond Air, Inc.$4.89MMicro cap+117.98%
GLMDGalmed Pharmaceuticals Ltd.$4.48MMicro cap+211.51%
SILOSilo Pharma, Inc.$4.38MMicro cap+290.62%
UPCUniverse Pharmaceuticals INC$3.53MMicro cap+44.57%
CLDICalidi Biotherapeutics, Inc.$3.49MMicro cap−19.16%
TNONTenon Medical, Inc.$3.48MMicro cap+297.71%
GNPXGenprex, Inc.$3.25MMicro cap−54.10%
BIAFbioAffinity Technologies, Inc.$3.02MMicro cap−31.59%
PFSAProfusa, Inc.$2.58MMicro cap−86.13%
VRAXVirax Biolabs Group Limited$2.21MMicro cap+365.55%
SHPHShuttle Pharmaceuticals Holdings, Inc.$2.10MMicro cap+7.65%
MNDRMobile-health Network Solutions$1.92MMicro cap−69.91%
SCNIScinai Immunotherapeutics Ltd.$1.48MMicro cap+93.92%
APMAptorum Group Ltd$570.06KMicro cap+273.78%
BTSGUBrightSpring Health Services, Inc.+142.79%
VERUVeru Inc.−14.89%

Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.

More ways to browse